Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2Lymphoid 2Plasma cell 1Other solid neoplasm 1Genitourinary 1Endocrine 1

Conditions

Breast Neoplasms 2Advanced Breast Cancer 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 183Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 93Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Moxifloxacin × Breast × Clear all
NCT05114720 2025-12-17

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Sun Yat-sen University

Phase 3 Completed
559 enrolled
Breast

Breast Neoplasms

NCT03405168 2018-11-16

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Sun Yat-sen University

Phase 2 Completed
35 enrolled
Breast

Advanced Breast Cancer

NCT00708903 2012-05-14

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

Puma Biotechnology, Inc.

Phase 1 Completed
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡